Clinical trial
To Investigate the Effect of Esketamine on Hemodynamics and Postoperative Pulmonary Complications in Patients Undergoing Heart Valve Replacement Surgery
NCT06467513 is registered in ClinicalTrials.gov with Zhang XIao Mei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Investigate the Effect of Esketamine on Hemodynamics and Postoperative Pulmonary Complications in Patients Undergoing Heart Valve Replacement Surgery
- Lead sponsor
- Zhang XIao Mei
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- May 31, 2025
- Enrollment
- 102 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.